Under construction – not a live service
Sign in
Taking peopleNo phase

Registry following people treated for brain blood vessel problems with Phenox devices

Follows people with brain aneurysms or vessel damage treated with Phenox devices.

Key facts

Who runs it
Phenox GmbH
Where
Basel and Sankt Gallen, SwitzerlandSee the 2 sitesAlso in 4 other countries, 11 sites
Trial code
Registry title
Targeting Real World Usage In Stroke Treatment
Status
Recruiting
People taking part
5,000 people, planned
Started
29 Jan 2026
Expected to end
Jan 2041
Type of study
Observational, 5 groups
Treatments tested
  • Aneurysm Treatment with a Neurovascular Flow Diverter
  • Dissection Treatment with a Neurovascular Flow Diverter
  • Perforation Treatment with a Neurovascular Flow Diverter
  • Arteriovenous Fistula treatment with a Neurovascular Flow Diverter
  • Aneurysm Treatment with Neurovascular Stent System
  • Atherosclerotic vascular stenosis Treatment with Neurovascular Stent System
  • Dissection Treatment with Neurovascular Stent System
  • Aneurysm treatment with Bifurcation Aneurysm Implant
  • Aneurysm treatment with Avenir Coil System
  • Arteriovenous fistula treatment with Avenir Coil System
Record updated
16 March 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The registry follows people who were treated, or are planned to be treated, with at least one WallabyPhenox device for blood vessel problems in the brain, such as aneurysms.

Sex
All sexes can join.
Earlier treatment
The person must have been treated, or be planned to be treated, with at least one registry device during the procedure.

Main reasons for not taking part

  • Taking part in an interventional study that changes standard care for all relevant conditions

The registry criteria, word for word

Show all 3 criteriaShow less

Who can take part

  • Subject treated or intended to be treated with at least one target registry device during the procedure (i.e., at least one attempt of introduction into the vasculature of the subject),
  • Non-opposition to data collection or informed consent provided by the subject or legal representative as per country-specific legislation

Who cannot take part

  • Participation in an interventional study modifying standard care management for all relevant indications,

Where in Switzerland

Also in 4 other countries, 11 sites

  • Universitätsspital BaselBasel, SwitzerlandContact: Marios-Nikos PSYCHOGIOS, Prof.Not yet recruiting
  • Kantonsspital St. GallenSankt Gallen, SwitzerlandContact: Victoria HELLSTERN, Dr.Not yet recruiting

About the trial

What the trial wants to find out

TRUST Registry is an observational, prospective, long-term, post-market surveillance registry of subjects treated with WallabyPhenox flow modulation devices, stent systems, bifurcation aneurysm implants including their HPC variants (Hydrophilic Polymer Coating) where applicable as well as coil systems, and other adjunctive medical devices.

Read full original descriptionShow less

The overarching purpose of this registry is to carry out a proactive gathering, recording, and analysis of data on the safety, performance and usability of the devices as applied within the routine practice of the participating registry sites.

The 5 groups in the trial

  • Treatment of Intracranial Aneurysm

    Patients undergoing treatment for intracranial aneurysms (IA) with market approved device(s) from WallabyPhenox implantable devices portfolio as per standard of care of participating hospitals. The cohort originates from one overarching registry protocol.

    Treatment: Aneurysm Treatment with a Neurovascular Flow Diverter, Aneurysm Treatment with Neurovascular Stent System, Aneurysm treatment with Bifurcation Aneurysm Implant, and Aneurysm treatment with Avenir Coil System

  • Treatment of Vascular Dissection

    Patients undergoing treatment for vascular dissection with market approved device(s) from WallabyPhenox implantable devices portfolio as per standard of care of participating hospitals. The cohort originates from one overarching registry protocol.

    Treatment: Dissection Treatment with a Neurovascular Flow Diverter and Dissection Treatment with Neurovascular Stent System

  • Treatment of Vascular Perforation

    Patients undergoing treatment for vascular perforation with market approved device(s) from WallabyPhenox implantable devices portfolio as per standard of care of participating hospitals. The cohort originates from one overarching registry protocol.

    Treatment: Perforation Treatment with a Neurovascular Flow Diverter

  • Treatment of Neurovascular Abnormalities

    Patients undergoing treatment for neurovascular abnormalities with market approved device(s) from WallabyPhenox implantable devices portfolio as per standard of care of participating hospitals. The cohort originates from one overarching registry protocol.

    Treatment: Arteriovenous Fistula treatment with a Neurovascular Flow Diverter and Arteriovenous fistula treatment with Avenir Coil System

  • Treatment of Atherosclerotic Vascular Stenosis of Intracranial Arteries

    Patients undergoing treatment for atherosclerotic vascular stenosis of intracranial arteries with market approved device(s) from WallabyPhenox implantable devices portfolio as per standard of care of participating hospitals. The cohort originates from one overarching registry protocol.

    Treatment: Atherosclerotic vascular stenosis Treatment with Neurovascular Stent System

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
TRUST Registry - Targeting Real World Usage In Stroke Treatment A WallabyPhenox Hemorrhagic Stroke Registry
Plain-language title
Registry following people treated for brain blood vessel problems with Phenox devicesGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 13 November 2026.
Record updated
16 March 2026